{('BRAF', 'NCT03750175'): [['Colorectal Cancer Metastatic', 'Circulating Tumor DNA', 'KRAS Gene Mutation', 'NRAS Gene Mutation', 'BRAF Gene Mutation', 'Epidermal Growth Factor Receptor Inhibitor'], ['Plasma circulating DNA analysis'], [], ['Aarhus University Hospital'], [], ['June 1, 2018']], ('BRAF', 'NCT02416232'): [['Melanoma'], ['Trametinib', 'Dabrafenib'], [], ['GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site', 'GSK Investigational Site'], [], []], ('BRAF', 'NCT02145910'): [['Recurrent Melanoma', 'Stage IV Melanoma', 'Tumors Metastatic to Brain'], ['Vemurafenib', 'Whole-brain radiation therapy (WBRT)', 'Radiosurgery (SRS)'], ['Phase 1'], [], [], []], ('BRCA1', 'NCT03211611'): [['BRCA1 Mutation', 'BRCA2 Mutation'], ['Questionnaire given to the two groups'], [], ['Uhmontpellier'], [], ['April 1, 2017']], ('BRCA1', 'NCT04012229'): [['Breast Cancer', 'BRCA1 Mutation', 'BRCA2 Mutation'], ['BRCA mutation'], [], ['University Hospital Jean Minjoz'], ['Franche-Comté'], ['July 28, 2017']], ('BRCA1', 'NCT03428399'): [['Breast Cancer', 'BRCA1 Mutation', 'BRCA2 Mutation'], ['Psychosocial variables'], [], ['Massachusetts General Hospital'], ['Massachusetts'], ['October 12, 2017']], ('BRCA1', 'NCT03684733'): [['BRCA1 Mutation', 'BRCA2 Mutation', 'Mammography', 'MRI'], ['MRI'], [], ['The Royal Marsden NHS Foundation Trust'], ['Surrey'], ['March 13, 2017']], ('BRCA1', 'NCT04095195'): [['Familial Pancreatic Cancer', 'BRCA1 Mutation', 'BRCA2 Mutation', 'Lynch Syndrome', 'FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome', 'Hereditary Pancreatitis', 'Peutz-Jeghers Syndrome'], ['MRCP', 'Endoultrasonography'], [], ['Istituto Clinico Humanitas', 'Ospedale Pederzoli', 'San Raffele Vita Salute University Hospital', 'Chirurgia Generale e del Pancreas'], ['Milan', 'Verona'], ['August 20, 2019']], ('BRCA1', 'NCT03835793'): [['Surgical Menopause', 'BRCA1 Mutation', 'BRCA2 Mutation', 'Cardiovascular Diseases', 'Bone Mineral Density', 'Cognitive Decline', 'Quality of Life', 'Menopause Surgical'], ['CAC-score'], [], ['Netherlands Cancer Institute - Antoni van Leeuwenhoek'], [], ['February 21, 2019']], ('BRCA1', 'NCT04108117'): [['Postoperative Complications', 'Recurrence', 'Breast Neoplasms', 'Breast Cancer', 'BRCA1 Mutation', 'BRCA2 Mutation', 'Surgery', 'Surgery--Complications'], ['Robotic nipple sparing mastectomy'], [], ['Yonsei University College of Medicine'], [], ['November 1, 2019']], ('BRCA1', 'NCT03396341'): [['Genetic Testing', 'BRCA1/2'], ['Salvia sample', 'Questionnaires'], [], ['Memorial Sloan-Kettering at Basking Ridge', 'Memorial Sloan Kettering Commack', 'Memoral Sloan Kettering Westchester', 'Memorial Sloan Kettering Cancer Center', 'Memorial Sloan Kettering Nassau'], ['New Jersey', 'New York', 'New York', 'New York', 'New York'], ['January 4, 2018']], ('BRCA1', 'NCT02985658'): [['Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation', 'Triple-Negative Breast Cancer'], ['Veliparib', 'Cisplatin', 'Vinorelbine'], [], ['Seattle Cancer Care Allliance'], ['Washington'], []], ('BRCA2', 'NCT03211611'): [['BRCA1 Mutation', 'BRCA2 Mutation'], ['Questionnaire given to the two groups'], [], ['Uhmontpellier'], [], ['April 1, 2017']], ('BRCA2', 'NCT04012229'): [['Breast Cancer', 'BRCA1 Mutation', 'BRCA2 Mutation'], ['BRCA mutation'], [], ['University Hospital Jean Minjoz'], ['Franche-Comté'], ['July 28, 2017']], ('BRCA2', 'NCT03428399'): [['Breast Cancer', 'BRCA1 Mutation', 'BRCA2 Mutation'], ['Psychosocial variables'], [], ['Massachusetts General Hospital'], ['Massachusetts'], ['October 12, 2017']], ('BRCA2', 'NCT03684733'): [['BRCA1 Mutation', 'BRCA2 Mutation', 'Mammography', 'MRI'], ['MRI'], [], ['The Royal Marsden NHS Foundation Trust'], ['Surrey'], ['March 13, 2017']], ('BRCA2', 'NCT04095195'): [['Familial Pancreatic Cancer', 'BRCA1 Mutation', 'BRCA2 Mutation', 'Lynch Syndrome', 'FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome', 'Hereditary Pancreatitis', 'Peutz-Jeghers Syndrome'], ['MRCP', 'Endoultrasonography'], [], ['Istituto Clinico Humanitas', 'Ospedale Pederzoli', 'San Raffele Vita Salute University Hospital', 'Chirurgia Generale e del Pancreas'], ['Milan', 'Verona'], ['August 20, 2019']], ('BRCA2', 'NCT03835793'): [['Surgical Menopause', 'BRCA1 Mutation', 'BRCA2 Mutation', 'Cardiovascular Diseases', 'Bone Mineral Density', 'Cognitive Decline', 'Quality of Life', 'Menopause Surgical'], ['CAC-score'], [], ['Netherlands Cancer Institute - Antoni van Leeuwenhoek'], [], ['February 21, 2019']], ('BRCA2', 'NCT04108117'): [['Postoperative Complications', 'Recurrence', 'Breast Neoplasms', 'Breast Cancer', 'BRCA1 Mutation', 'BRCA2 Mutation', 'Surgery', 'Surgery--Complications'], ['Robotic nipple sparing mastectomy'], [], ['Yonsei University College of Medicine'], [], ['November 1, 2019']], ('BRCA2', 'NCT02985658'): [['Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation', 'Triple-Negative Breast Cancer'], ['Veliparib', 'Cisplatin', 'Vinorelbine'], [], ['Seattle Cancer Care Allliance'], ['Washington'], []], ('BRIP1', 'NCT04009148'): [['BRCA-Mutated Ovarian Carcinoma', 'BRIP1 Gene Mutation', 'MSH2 A636P', 'MLH1 Gene Mutation', 'MSH6 Gene Mutation', 'PMS2 Gene Mutation', 'EPCAM', 'RAD51C Gene Mutation'], ['CASCADE genetic screening'], [], ['NYU Langone Health'], ['New York'], ['March 1, 2019']], ('CDKN2A', 'NCT03524677'): [['Pancreatic Cancer'], ['Liquid Biopsy'], [], ['St Vincent university Hospital', 'Policlinico Universitario Agostino Gemelli', "AOU Sant'Andrea - UOC Chirurgia Generale"], [], ['January 23, 2019']], ('EGFR', 'NCT04122833'): [['Adenocarcinoma of Lung', 'EGFR Activating Mutation'], ['Next generation sequencing'], [], ['Asan medical center', "Catholic university medical center, Seoul St. Mary's Hospital"], [], ['September 30, 2019']], ('EGFR', 'NCT03647592'): [['Efficacy and Safety of Erlotinib/Gefitinib Combined With Bevacizumab in EGFR Mutation Positive Advanced Non-squamous Non-small Cell Lung Cancer'], ['Erlotinib/Gefitinib combined with Bevacizumab'], [], ['Hunan Provincal Tumor Hospital'], ['Hunan'], ['June 1, 2018']], ('EGFR', 'NCT02451852'): [['EGFR T790M Mutation Positive NSCLC'], ['AZD9291'], [], ['Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site'], ['California', 'California', 'California', 'California', 'California', 'Connecticut', 'Florida', 'Florida', 'Georgia', 'Hawaii', 'Illinois', 'Maryland', 'Massachusetts', 'Michigan', 'Michigan', 'Minnesota', 'Nebraska', 'New Jersey', 'New York', 'New York', 'New York', 'New York', 'North Carolina', 'North Carolina', 'Ohio', 'South Dakota', 'Texas', 'Texas', 'Virginia', 'Virginia', 'Washington', 'Washington'], []], ('EGFR', 'NCT03519958'): [['Non-small Cell Lung Cancer'], ['Plasma-tissue testing'], [], [], [], ['September 30, 2018']], ('EGFR', 'NCT03137264'): [['Non-small Cell Lung Cancer'], ['Other'], [], ['Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site', 'Research Site'], ['California', 'California', 'California', 'California', 'Florida', 'Florida', 'Hawaii', 'Idaho', 'Illinois', 'Illinois', 'Maryland', 'Michigan', 'New Jersey', 'New Mexico', 'New York', 'North Carolina', 'North Carolina', 'Ohio', 'Washington', 'Washington', 'Alberta', 'Ontario', 'Quebec'], ['October 24, 2017']], ('EGFR', 'NCT03790397'): [['Non Small Cell Lung Cancer'], ['Osimertinib'], [], ['Hospital Universitario Central de Asturias', 'ICO Badalona', 'Hospital Clínico Universitario de Santiago', 'Complejo Hospitalario Universitario A Coruña', 'Hospital Universitario Dr. Negrín', 'Hospital Príncipe de Asturias', 'Hospital Universitario de Getafe', 'Hospital Universitari Son Espases', 'Hospital Universitario Son Llàtzer', 'Complejo Hospitalario Universitario de Vigo', 'Hospital Lluís Alcanyís', 'Hospital General de Albacete', 'Hospital General Universitario Alicante', 'Hospital de Sant Pau', 'Hospital Universitario de Burgos', 'Hospital Dr. Josep Trueta', 'Hospital Universitario de Guadalajara', 'Complejo Hospitalario de Jaén', 'Complejo Asistencial Universitario de León', 'Hospital Universitario Lucus Augusti', 'Hospital Ramón y Cajal', 'Hospital Clínico San Carlos', 'Hospital Universitario Puerta de Hierro', 'Hospital General Universitario de Málaga', 'Hospital Clínico de Salamanca', 'Hospital Virgen del Rocío', 'Hospital Virgen de la Salud', 'Hospital Virgen de la Salud', 'Hospital Universitari i Politécnic La Fe', 'Hospital General Universitario de Valencia', 'Hospital Clínico Universitario de Valladolid', 'Hospital Clínico Lozano Blesa'], ['Asturias', 'Barcelona', 'Galicia', 'La Coruña', 'Las Palmas', 'Madrid', 'Madrid', 'Mallorca', 'Mallorca', 'Pontevedra', 'Valencia'], ['February 26, 2019']], ('EGFR', 'NCT03133234'): [['T790M Positive NSCLC Patients'], ['osimertinib'], [], ['Kiang Wu Hospital'], [], ['May 23, 2017']], ('EGFR', 'NCT03750175'): [['Colorectal Cancer Metastatic', 'Circulating Tumor DNA', 'KRAS Gene Mutation', 'NRAS Gene Mutation', 'BRAF Gene Mutation', 'Epidermal Growth Factor Receptor Inhibitor'], ['Plasma circulating DNA analysis'], [], ['Aarhus University Hospital'], [], ['June 1, 2018']], ('EGFR', 'NCT02547675'): [['Non-small Cell Lung Cancer'], ['Rociletinib'], [], ['Mayo Clinic Arizona', 'Compassionate Care Research Group, Inc.', 'Pacific Cancer Care', 'Sutter Cancer Institute', 'UCSF Helen Diller Family Comprehensive Cancer Center', 'Halifax Health - Center for Oncology', 'UF Health Center Orlando', 'Beth Israel Deaconess Medical Center', 'Henry Ford Hospital', 'Billings Clinic', 'Tulsa Cancer Institute'], ['Arizona', 'California', 'California', 'California', 'California', 'Florida', 'Florida', 'Massachusetts', 'Michigan', 'Montana', 'Oklahoma'], []], ('EGFR', 'NCT03370770'): [['Carcinoma, Non-Small-Cell Lung'], ['Afatinib', 'Osimertinib'], [], ['Otto-Wagner Hospital'], [], ['December 28, 2017']], ('EGFR', 'NCT01931306'): [['Carcinoma, Non-Small-Cell Lung'], ['Afatinib'], [], ["The Catholic University of Korea, Bucheon St.Mary's Hospital", 'Gachon University Gil Medical Center', 'Chonnam National University Hwasun Hospital', 'Gyeongsang National University Hospital', "The Catholic University of Korea, Seoul St.Mary's Hospital", 'Severance Hospital', 'Samsung Medical Center', 'SMG-SNU Boramae Medical Center'], [], []], ('EGFR', 'NCT01297101'): [['Non-small Cell Lung Cancer'], ['Erlotinib'], [], [], [], []], ('EGFR', 'NCT03219970'): [['Non-small Cell Lung Cancer'], ['Osimertinib'], [], ['Pamela Youde Nethersole Eastern Hospital', 'Prince of wales hospital', 'Queen Mary Hospital', 'Tuen Mun Hospital'], [], ['September 5, 2017']], ('EPCAM', 'NCT04009148'): [['BRCA-Mutated Ovarian Carcinoma', 'BRIP1 Gene Mutation', 'MSH2 A636P', 'MLH1 Gene Mutation', 'MSH6 Gene Mutation', 'PMS2 Gene Mutation', 'EPCAM', 'RAD51C Gene Mutation'], ['CASCADE genetic screening'], [], ['NYU Langone Health'], ['New York'], ['March 1, 2019']], ('ERBB2', 'NCT03786107'): [['Metastatic Breast Cancer', 'Metastatic Cervical Cancer'], ['Almac HER-Seq Assay Kit'], [], ['Cork University Hospital', "St. Vincent's University Hospital", 'Mater Misericordiae University Hospital, Institute for Cancer Research', 'Beaumont Hospital, Cancer Clinical Trials & Research Unit', 'University Hospital Waterford, Department of Medical Oncology', 'Institute for Oncology and Radiology of Serbia', 'Hospital Universitario Quirónsalud Madrid', 'Instituto Oncológico Dr. Rosell, Hospital Universitario Quirón Dexeus', "Hospital Universitari Vall D'Hebron", 'Hospital Clinic de Barcelona', 'Hospital Clínico San Carlos', 'START Madrid, Hospital Universitario Fundacion Jimenez Diaz', 'Hospital Universitario Madrid Sanchinarro', 'Fundación Instituto Valenciano de Oncológia', 'Hospital Clínico Universitario de Valencia'], ['Cork', 'Dublin', 'Madrid'], ['March 14, 2019']], ('ERBB2', 'NCT03947736'): [['Recurrent or Metastatic Breast Cancer'], ['cfDNA was detected by dPCR'], [], ['Chinese Academy of Medical Sciences'], ['Beijing'], ['September 17, 2018']], ('FLT1', 'NCT03070093'): [['Acute Myeloid Leukemia (AML)', 'FMS-like Tyrosine Kinase-3 (FLT3) Mutations'], ['gilteritinib'], [], ['UCLA', 'Rocky Mountain Cancer Center-M', 'Memorial Healthcare System', 'Northside Hospital', 'Georgia Cancer Center at Augusta University', 'Northwestern University Medical Center', 'University of Chicago', 'Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis', 'Norton Cancer Institute', 'Tulane University', 'University of Maryland Medical Center', 'Johns Hopkins Hospital', 'The Sidney Kimmel Comprehensive Cancer Center -Johns Hopkins University', 'Massachusetts General Hospital', 'Beth Israel Deaconess Medical Center', 'Dana Farber Cancer Institute', 'West Michigan Regional Cancer Center', 'Washington University School of Medicine', 'New Mexico Cancer Care Alliance', 'Roswell Park Cancer Institute', 'Memorial Sloan Kettering', 'Weill Cornell Medical College', 'Duke University Medical Center', 'Wake Forest Baptist Hospital', 'Ohio State University', 'Providence Portland Medical Center', 'Penn State Hershey Medical Center', 'Thomas Jefferson University', 'UPCI', 'Vanderbilt University', 'Huntsman Cancer Institute University of Utah', 'WVU Medicine Cancer', 'Site CA15002', 'Site CA15003', 'Site CA15001', 'Site JP81001', 'Site JP81002', 'Site JP81003'], ['California', 'Colorado', 'Florida', 'Georgia', 'Georgia', 'Illinois', 'Illinois', 'Indiana', 'Kentucky', 'Louisiana', 'Maryland', 'Maryland', 'Maryland', 'Massachusetts', 'Massachusetts', 'Massachusetts', 'Michigan', 'Missouri', 'New Mexico', 'New York', 'New York', 'New York', 'North Carolina', 'North Carolina', 'Ohio', 'Oregon', 'Pennsylvania', 'Pennsylvania', 'Pennsylvania', 'Tennessee', 'Utah', 'West Virginia', 'Nova Scotia', 'Ontario', 'Quebec', 'Aichi', 'Tokyo'], []], ('FLT1', 'NCT03409081'): [['Acute Myeloid Leukemia (AML)', 'FMS-like Tyrosine Kinase-3 (FLT3) Mutations'], ['gilteritinib'], [], ['Site AU61001', 'Site IT39001', 'Site IT39003', 'Site UK44001', 'Site UK44003', 'Site UK44002'], [], []], ('FLT1', 'NCT03620318'): [['FLT3-ITD Mutation', 'FLT3/TKD Mutation', 'PDGFR-Alpha D842V', 'PDGFRA Gene Amplification'], ['Crenolanib besylate'], [], ['Ospedale Policlinico San Martino'], [], []], ('FLT1', 'NCT02624570'): [['Acute Myeloid Leukemia (AML) With', 'FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)'], ['Midostaurin'], [], ['Mayo Clinic Arizona', 'The Jordan Research and Education Center ABSMC Comprehensive Cancer Ctr', 'City of Hope National Medical Center Department of Hematology & HCT', 'St. Judes Medical Center', 'University of Calif Irvine Medical Center Family Comp Cancer Cntr', 'Kaiser Permanente Northwest Kaiser', 'Poudre Valley Hospital Poudre Valley Hospital -U of C', 'Memorial Healthcare System Memorial Healthcare System', 'UF Health Cancer Center at Orlando Health Orlando Health', 'H Lee Moffitt Cancer Center and Research Institute SC - 5', 'Augusta University Georgia Cancer Center Pharmacy', 'Rush University Medical Center Dept.of Rush UniversityMedCtr.', 'University of Chicago Medical Center', 'Indiana Blood and Marrow Institute Indiana Blood and Marrow Trans', 'Ft. Wayne Medical Oncology & Hematology, Inc.', 'Norton Cancer Institute Norton Cancer Institute', 'University of Louisville / James Graham Brown Cancer Center Louisville 529-539', 'Tulane University Medical Center', 'Oschner Clinic Foundation', 'Tufts Medical Center', 'Karmanos Cancer Institute Harper Hosp. Invest. Pharmacy', 'Henry Ford Hospital SC', 'Mayo Clinic Mayo Clinic', 'Nebraska Cancer Specialist/Missouri Valley Cancer Consortium', 'Healthcare Partners Medical Group', 'Weill Cornell Medical College NY Presbyterian Hospital', 'University of Rochester Medical Center Univ of Rochester (7)', 'Kaiser Permanente NW Region Kaiser Permanente Northwest', 'Penn State University / Milton S. Hershey Medical Center Penn State Cancer Institute', 'University of Pennsylvania Cancer Center University of Pen/Abr Canc ctr', 'Medical University of South Carolina Hematology-Oncology Division', 'Erlanger Medical Center Erlanger Health System', 'Vanderbilt University Medical Center, Clinical Trials Center Division Hematology/Oncology', 'University of Texas Medical Branch University of Texas MB', 'McGovern Medical School at the University of Texas Health', 'Oncology Consultants Oncology Consultants', 'Methodist Healthcare System', 'Intermountain Healthcare - Huntsman Cancer Clinics Intermountain Healthcare (2)', 'Huntsman Cancer Institute Univ of Utah', 'Virginia Oncology Associates Virginia Oncology Assoc. (6)', 'Swedish Cancer Institute Cancer Institute', 'Veterans Affairs Puget Sound Health Care System VAMC Seattle, WA Divison', 'Wenatchee Valley Hospital and Clinics', 'Cheyenne Regional Medical Center'], ['Arizona', 'California', 'California', 'California', 'California', 'Colorado', 'Colorado', 'Florida', 'Florida', 'Florida', 'Georgia', 'Illinois', 'Illinois', 'Indiana', 'Indiana', 'Kentucky', 'Kentucky', 'Louisiana', 'Louisiana', 'Massachusetts', 'Michigan', 'Michigan', 'Minnesota', 'Nebraska', 'Nevada', 'New York', 'New York', 'Oregon', 'Pennsylvania', 'Pennsylvania', 'South Carolina', 'Tennessee', 'Tennessee', 'Texas', 'Texas', 'Texas', 'Texas', 'Utah', 'Utah', 'Virginia', 'Washington', 'Washington', 'Washington', 'Wyoming'], []], ('FLT3', 'NCT03746912'): [['Acute Myeloid Leukemia With Gene Mutations'], ['Quizartinib Dihydrochloride'], [], [], [], []], ('FLT3', 'NCT03070093'): [['Acute Myeloid Leukemia (AML)', 'FMS-like Tyrosine Kinase-3 (FLT3) Mutations'], ['gilteritinib'], [], ['UCLA', 'Rocky Mountain Cancer Center-M', 'Memorial Healthcare System', 'Northside Hospital', 'Georgia Cancer Center at Augusta University', 'Northwestern University Medical Center', 'University of Chicago', 'Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis', 'Norton Cancer Institute', 'Tulane University', 'University of Maryland Medical Center', 'Johns Hopkins Hospital', 'The Sidney Kimmel Comprehensive Cancer Center -Johns Hopkins University', 'Massachusetts General Hospital', 'Beth Israel Deaconess Medical Center', 'Dana Farber Cancer Institute', 'West Michigan Regional Cancer Center', 'Washington University School of Medicine', 'New Mexico Cancer Care Alliance', 'Roswell Park Cancer Institute', 'Memorial Sloan Kettering', 'Weill Cornell Medical College', 'Duke University Medical Center', 'Wake Forest Baptist Hospital', 'Ohio State University', 'Providence Portland Medical Center', 'Penn State Hershey Medical Center', 'Thomas Jefferson University', 'UPCI', 'Vanderbilt University', 'Huntsman Cancer Institute University of Utah', 'WVU Medicine Cancer', 'Site CA15002', 'Site CA15003', 'Site CA15001', 'Site JP81001', 'Site JP81002', 'Site JP81003'], ['California', 'Colorado', 'Florida', 'Georgia', 'Georgia', 'Illinois', 'Illinois', 'Indiana', 'Kentucky', 'Louisiana', 'Maryland', 'Maryland', 'Maryland', 'Massachusetts', 'Massachusetts', 'Massachusetts', 'Michigan', 'Missouri', 'New Mexico', 'New York', 'New York', 'New York', 'North Carolina', 'North Carolina', 'Ohio', 'Oregon', 'Pennsylvania', 'Pennsylvania', 'Pennsylvania', 'Tennessee', 'Utah', 'West Virginia', 'Nova Scotia', 'Ontario', 'Quebec', 'Aichi', 'Tokyo'], []], ('FLT3', 'NCT03620318'): [['FLT3-ITD Mutation', 'FLT3/TKD Mutation', 'PDGFR-Alpha D842V', 'PDGFRA Gene Amplification'], ['Crenolanib besylate'], [], ['Ospedale Policlinico San Martino'], [], []], ('FLT3', 'NCT02624570'): [['Acute Myeloid Leukemia (AML) With', 'FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)'], ['Midostaurin'], [], ['Mayo Clinic Arizona', 'The Jordan Research and Education Center ABSMC Comprehensive Cancer Ctr', 'City of Hope National Medical Center Department of Hematology & HCT', 'St. Judes Medical Center', 'University of Calif Irvine Medical Center Family Comp Cancer Cntr', 'Kaiser Permanente Northwest Kaiser', 'Poudre Valley Hospital Poudre Valley Hospital -U of C', 'Memorial Healthcare System Memorial Healthcare System', 'UF Health Cancer Center at Orlando Health Orlando Health', 'H Lee Moffitt Cancer Center and Research Institute SC - 5', 'Augusta University Georgia Cancer Center Pharmacy', 'Rush University Medical Center Dept.of Rush UniversityMedCtr.', 'University of Chicago Medical Center', 'Indiana Blood and Marrow Institute Indiana Blood and Marrow Trans', 'Ft. Wayne Medical Oncology & Hematology, Inc.', 'Norton Cancer Institute Norton Cancer Institute', 'University of Louisville / James Graham Brown Cancer Center Louisville 529-539', 'Tulane University Medical Center', 'Oschner Clinic Foundation', 'Tufts Medical Center', 'Karmanos Cancer Institute Harper Hosp. Invest. Pharmacy', 'Henry Ford Hospital SC', 'Mayo Clinic Mayo Clinic', 'Nebraska Cancer Specialist/Missouri Valley Cancer Consortium', 'Healthcare Partners Medical Group', 'Weill Cornell Medical College NY Presbyterian Hospital', 'University of Rochester Medical Center Univ of Rochester (7)', 'Kaiser Permanente NW Region Kaiser Permanente Northwest', 'Penn State University / Milton S. Hershey Medical Center Penn State Cancer Institute', 'University of Pennsylvania Cancer Center University of Pen/Abr Canc ctr', 'Medical University of South Carolina Hematology-Oncology Division', 'Erlanger Medical Center Erlanger Health System', 'Vanderbilt University Medical Center, Clinical Trials Center Division Hematology/Oncology', 'University of Texas Medical Branch University of Texas MB', 'McGovern Medical School at the University of Texas Health', 'Oncology Consultants Oncology Consultants', 'Methodist Healthcare System', 'Intermountain Healthcare - Huntsman Cancer Clinics Intermountain Healthcare (2)', 'Huntsman Cancer Institute Univ of Utah', 'Virginia Oncology Associates Virginia Oncology Assoc. (6)', 'Swedish Cancer Institute Cancer Institute', 'Veterans Affairs Puget Sound Health Care System VAMC Seattle, WA Divison', 'Wenatchee Valley Hospital and Clinics', 'Cheyenne Regional Medical Center'], ['Arizona', 'California', 'California', 'California', 'California', 'Colorado', 'Colorado', 'Florida', 'Florida', 'Florida', 'Georgia', 'Illinois', 'Illinois', 'Indiana', 'Indiana', 'Kentucky', 'Kentucky', 'Louisiana', 'Louisiana', 'Massachusetts', 'Michigan', 'Michigan', 'Minnesota', 'Nebraska', 'Nevada', 'New York', 'New York', 'Oregon', 'Pennsylvania', 'Pennsylvania', 'South Carolina', 'Tennessee', 'Tennessee', 'Texas', 'Texas', 'Texas', 'Texas', 'Utah', 'Utah', 'Virginia', 'Washington', 'Washington', 'Washington', 'Wyoming'], []], ('FLT3', 'NCT03409081'): [['Acute Myeloid Leukemia (AML)', 'FMS-like Tyrosine Kinase-3 (FLT3) Mutations'], ['gilteritinib'], [], ['Site AU61001', 'Site IT39001', 'Site IT39003', 'Site UK44001', 'Site UK44003', 'Site UK44002'], [], []], ('FLT3', 'NCT02723435'): [['Acute Myeloid Leukemia With Gene Mutations', 'Adult Acute Myeloid Leukemia in Remission'], ['Midostaurin'], ['Phase 2'], [], [], []], ('IDH1', 'NCT03245424'): [['Acute Myeloid Leukemia', 'Relapsed Adult AML', 'Relapsed Pediatric AML'], ['ivosidenib (AG-120)'], [], [], [], []], ('IDH1', 'NCT03204838'): [['Acute Myeloid Leukemia (AML)'], ['IDH mutation test performed at diagnosis'], [], ['Ciudad de Mexico'], [], ['July 10, 2017']], ('IDH1', 'NCT02986620'): [['AML, Adult'], ['IDH mutation test performed at diagnosis or relapse until January 31st, 2019.'], [], ['Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi', 'AOU Policlinico G. Martino', "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano", 'UO Ematologia _AOU Policlinico di Modena', 'Università degli Studi di Padova - Ematologia ed Immunologia Clinica', 'AU Policlinico "Paiolo Giaccone"', 'Sezione di ematologia ed immunologia - Clinica Ospedale S. Maria della Misericordia', 'IFO Istituto Nazionale Tumori Regina Elena', 'Università Cattolica del Sacro Cuore - Policlinico A.Gemelli', 'Università degli Studi - Policlinico di Tor Vergata', 'Università degli Studi - Policlinico Tor Vergata'], [], ['October 31, 2017']], ('IDH2', 'NCT03204838'): [['Acute Myeloid Leukemia (AML)'], ['IDH mutation test performed at diagnosis'], [], ['Ciudad de Mexico'], [], ['July 10, 2017']], ('IDH2', 'NCT02986620'): [['AML, Adult'], ['IDH mutation test performed at diagnosis or relapse until January 31st, 2019.'], [], ['Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi', 'AOU Policlinico G. Martino', "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano", 'UO Ematologia _AOU Policlinico di Modena', 'Università degli Studi di Padova - Ematologia ed Immunologia Clinica', 'AU Policlinico "Paiolo Giaccone"', 'Sezione di ematologia ed immunologia - Clinica Ospedale S. Maria della Misericordia', 'IFO Istituto Nazionale Tumori Regina Elena', 'Università Cattolica del Sacro Cuore - Policlinico A.Gemelli', 'Università degli Studi - Policlinico di Tor Vergata', 'Università degli Studi - Policlinico Tor Vergata'], [], ['October 31, 2017']], ('KRAS', 'NCT03647098'): [['KRAS Gene Mutation Advanced Non-small Cell Lung Cancer'], ['kras'], [], ['Hunan Provincal Tumor Hospital'], ['Hunan'], ['August 1, 2018']], ('KRAS', 'NCT03750175'): [['Colorectal Cancer Metastatic', 'Circulating Tumor DNA', 'KRAS Gene Mutation', 'NRAS Gene Mutation', 'BRAF Gene Mutation', 'Epidermal Growth Factor Receptor Inhibitor'], ['Plasma circulating DNA analysis'], [], ['Aarhus University Hospital'], [], ['June 1, 2018']], ('KRAS', 'NCT03524677'): [['Pancreatic Cancer'], ['Liquid Biopsy'], [], ['St Vincent university Hospital', 'Policlinico Universitario Agostino Gemelli', "AOU Sant'Andrea - UOC Chirurgia Generale"], [], ['January 23, 2019']], ('MET', 'NCT03314649'): [['Gastric Cancer'], ['Observational study'], [], ['Cancer Center of Sun Yat-sen University'], ['Guangdong'], ['December 21, 2017']], ('MET', 'NCT03257735'): [['Lung Cancer', 'Brain Metastases', 'Cerebrospinal Fluid', 'Next-generation Sequencing'], ['next-generation sequencing'], [], ['Sun Yat-sen University Cancer Center'], ['Guangdong'], ['May 1, 2017']], ('MET', 'NCT03958565'): [['Carcinoma, Non-Small-Cell Lung'], ['Tyrosine Kinase Inhibitor', 'Zoledronic Acid 4 MG/100 ML Intravenous Solution [ZOMETA]', 'Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]'], [], ['University of Colorado Hospital'], ['Colorado'], ['April 15, 2019']], ('MET', 'NCT02145910'): [['Recurrent Melanoma', 'Stage IV Melanoma', 'Tumors Metastatic to Brain'], ['Vemurafenib', 'Whole-brain radiation therapy (WBRT)', 'Radiosurgery (SRS)'], ['Phase 1'], [], [], []], ('MLH1', 'NCT04009148'): [['BRCA-Mutated Ovarian Carcinoma', 'BRIP1 Gene Mutation', 'MSH2 A636P', 'MLH1 Gene Mutation', 'MSH6 Gene Mutation', 'PMS2 Gene Mutation', 'EPCAM', 'RAD51C Gene Mutation'], ['CASCADE genetic screening'], [], ['NYU Langone Health'], ['New York'], ['March 1, 2019']], ('MSH6', 'NCT04009148'): [['BRCA-Mutated Ovarian Carcinoma', 'BRIP1 Gene Mutation', 'MSH2 A636P', 'MLH1 Gene Mutation', 'MSH6 Gene Mutation', 'PMS2 Gene Mutation', 'EPCAM', 'RAD51C Gene Mutation'], ['CASCADE genetic screening'], [], ['NYU Langone Health'], ['New York'], ['March 1, 2019']], ('MTOR', 'NCT03817515'): [['PEComa, Malignant', 'TSC1', 'TSC2', 'mTOR Pathway Abberation'], ['ABI-009'], [], [], [], []], ('NF1', 'NCT03259633'): [['NF type1 With Inoperable Plexiform Neurofibromas'], ['Selumetinib'], [], ["Children's of Alabama", 'Kaiser Permanente Oakland Medical Center', "CHOC Children's of Orange County", "Presbyterian/St. Luke's Medical Center", 'Alfred I. DuPont Hospital for Children', "Children's National Medical Center", "St. Luke's Health System", "Lurie Children's Hospital", 'Indiana University Health', 'Our Lady of the Lake - St. Jude Affiliate Clinic', 'Ochsner Medical Center', 'Willis-Knight Cancer Center', 'Maine Medical Center', 'National Institute of Health', 'Tufts Medical Center', 'Michigan Medicine', 'Spectrum Health', "Children's Minnesota", 'University of Mississippi Medical Center', "SSM Cardinal Glennon Children's Hospital", 'Washington University in St. Louis', 'Albany Medical Center', 'Memorial Sloan Kettering', 'Duke University', 'University Hospitals Cleveland Medical Center', 'Jimmy Everest Cancer Center', "The Children's Hospital of Philadelphia", 'University of Pittsburgh Medical Center', 'PrismaHealth Upstate', "St Jude Children's Research Hospital", 'Vanderbilt University Medical Center', "Dell Children's Medical Center", 'Center for Oncology and Blood Disorders', "Texas Children's Hospital", "Children's Hospital of San Antonio", 'University of Utah', "Children's Hospital of Wisconsin"], ['Alabama', 'California', 'California', 'Colorado', 'Delaware', 'District of Columbia', 'Idaho', 'Illinois', 'Indiana', 'Louisiana', 'Louisiana', 'Louisiana', 'Maine', 'Maryland', 'Massachusetts', 'Michigan', 'Michigan', 'Minnesota', 'Mississippi', 'Missouri', 'Missouri', 'New York', 'New York', 'North Carolina', 'Ohio', 'Oklahoma', 'Pennsylvania', 'Pennsylvania', 'South Carolina', 'Tennessee', 'Tennessee', 'Texas', 'Texas', 'Texas', 'Texas', 'Utah', 'Wisconsin'], []], ('NRAS', 'NCT03750175'): [['Colorectal Cancer Metastatic', 'Circulating Tumor DNA', 'KRAS Gene Mutation', 'NRAS Gene Mutation', 'BRAF Gene Mutation', 'Epidermal Growth Factor Receptor Inhibitor'], ['Plasma circulating DNA analysis'], [], ['Aarhus University Hospital'], [], ['June 1, 2018']], ('NTRK1', 'NCT02624570'): [['Acute Myeloid Leukemia (AML) With', 'FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)'], ['Midostaurin'], [], ['Mayo Clinic Arizona', 'The Jordan Research and Education Center ABSMC Comprehensive Cancer Ctr', 'City of Hope National Medical Center Department of Hematology & HCT', 'St. Judes Medical Center', 'University of Calif Irvine Medical Center Family Comp Cancer Cntr', 'Kaiser Permanente Northwest Kaiser', 'Poudre Valley Hospital Poudre Valley Hospital -U of C', 'Memorial Healthcare System Memorial Healthcare System', 'UF Health Cancer Center at Orlando Health Orlando Health', 'H Lee Moffitt Cancer Center and Research Institute SC - 5', 'Augusta University Georgia Cancer Center Pharmacy', 'Rush University Medical Center Dept.of Rush UniversityMedCtr.', 'University of Chicago Medical Center', 'Indiana Blood and Marrow Institute Indiana Blood and Marrow Trans', 'Ft. Wayne Medical Oncology & Hematology, Inc.', 'Norton Cancer Institute Norton Cancer Institute', 'University of Louisville / James Graham Brown Cancer Center Louisville 529-539', 'Tulane University Medical Center', 'Oschner Clinic Foundation', 'Tufts Medical Center', 'Karmanos Cancer Institute Harper Hosp. Invest. Pharmacy', 'Henry Ford Hospital SC', 'Mayo Clinic Mayo Clinic', 'Nebraska Cancer Specialist/Missouri Valley Cancer Consortium', 'Healthcare Partners Medical Group', 'Weill Cornell Medical College NY Presbyterian Hospital', 'University of Rochester Medical Center Univ of Rochester (7)', 'Kaiser Permanente NW Region Kaiser Permanente Northwest', 'Penn State University / Milton S. Hershey Medical Center Penn State Cancer Institute', 'University of Pennsylvania Cancer Center University of Pen/Abr Canc ctr', 'Medical University of South Carolina Hematology-Oncology Division', 'Erlanger Medical Center Erlanger Health System', 'Vanderbilt University Medical Center, Clinical Trials Center Division Hematology/Oncology', 'University of Texas Medical Branch University of Texas MB', 'McGovern Medical School at the University of Texas Health', 'Oncology Consultants Oncology Consultants', 'Methodist Healthcare System', 'Intermountain Healthcare - Huntsman Cancer Clinics Intermountain Healthcare (2)', 'Huntsman Cancer Institute Univ of Utah', 'Virginia Oncology Associates Virginia Oncology Assoc. (6)', 'Swedish Cancer Institute Cancer Institute', 'Veterans Affairs Puget Sound Health Care System VAMC Seattle, WA Divison', 'Wenatchee Valley Hospital and Clinics', 'Cheyenne Regional Medical Center'], ['Arizona', 'California', 'California', 'California', 'California', 'Colorado', 'Colorado', 'Florida', 'Florida', 'Florida', 'Georgia', 'Illinois', 'Illinois', 'Indiana', 'Indiana', 'Kentucky', 'Kentucky', 'Louisiana', 'Louisiana', 'Massachusetts', 'Michigan', 'Michigan', 'Minnesota', 'Nebraska', 'Nevada', 'New York', 'New York', 'Oregon', 'Pennsylvania', 'Pennsylvania', 'South Carolina', 'Tennessee', 'Tennessee', 'Texas', 'Texas', 'Texas', 'Texas', 'Utah', 'Utah', 'Virginia', 'Washington', 'Washington', 'Washington', 'Wyoming'], []], ('NTRK1', 'NCT03114228'): [['FLT3-mutated Acute Myeloid Leukemia'], ['Midostaurin'], [], ['Novartis Investigative Site', 'Novartis Investigative Site'], ['Ontario', 'Quebec'], []], ('PDGFRA', 'NCT03620318'): [['FLT3-ITD Mutation', 'FLT3/TKD Mutation', 'PDGFR-Alpha D842V', 'PDGFRA Gene Amplification'], ['Crenolanib besylate'], [], ['Ospedale Policlinico San Martino'], [], []], ('PIK3CA', 'NCT03317366'): [['Proteus Syndrome', 'PIK3CA-Related Overgrowth Spectrum (PROS)', 'Growth Disorders'], ['ARQ 092'], [], [], [], []], ('RAD51C', 'NCT04009148'): [['BRCA-Mutated Ovarian Carcinoma', 'BRIP1 Gene Mutation', 'MSH2 A636P', 'MLH1 Gene Mutation', 'MSH6 Gene Mutation', 'PMS2 Gene Mutation', 'EPCAM', 'RAD51C Gene Mutation'], ['CASCADE genetic screening'], [], ['NYU Langone Health'], ['New York'], ['March 1, 2019']], ('SMAD4', 'NCT03524677'): [['Pancreatic Cancer'], ['Liquid Biopsy'], [], ['St Vincent university Hospital', 'Policlinico Universitario Agostino Gemelli', "AOU Sant'Andrea - UOC Chirurgia Generale"], [], ['January 23, 2019']], ('SRSF2', 'NCT03894852'): [['Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia'], ['PCR and cytogenetics'], [], [], [], ['June 2019']], ('TP53', 'NCT03927599'): [['Solid Tumor, Adult'], ['Data Collection'], [], ['Tianjin Medical Unversity Second Hospital'], ['Tianjin'], ['August 1, 2018']], ('TP53', 'NCT03524677'): [['Pancreatic Cancer'], ['Liquid Biopsy'], [], ['St Vincent university Hospital', 'Policlinico Universitario Agostino Gemelli', "AOU Sant'Andrea - UOC Chirurgia Generale"], [], ['January 23, 2019']], ('TSC1', 'NCT03817515'): [['PEComa, Malignant', 'TSC1', 'TSC2', 'mTOR Pathway Abberation'], ['ABI-009'], [], [], [], []], ('TSC2', 'NCT03817515'): [['PEComa, Malignant', 'TSC1', 'TSC2', 'mTOR Pathway Abberation'], ['ABI-009'], [], [], [], []]}